A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer.

Mol Cancer

Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chemistry and Biomedicine Innovation Center (ChemBIC), State Key Laboratory of Pharmaceutical Biotechnology and Department of Physiology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), School of Life Sciences, Nanjing University, Nanjing, 210023, China.

Published: July 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285832PMC
http://dx.doi.org/10.1186/s12943-021-01389-5DOI Listing

Publication Analysis

Top Keywords

novel class
4
class tsrna
4
tsrna signatures
4
signatures biomarkers
4
biomarkers diagnosis
4
diagnosis prognosis
4
prognosis pancreatic
4
pancreatic cancer
4
novel
1
tsrna
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!